|
|
Dr. Eric S.
Freedland |
|
 Dr.
Freedland continues his series “Why Focusing On Intensive Glucose
Control With Drugs Alone Is Counterproductive” with part
4
Insulin’s
contribution to obesity
Eric S. Freedland, MD
|
|
|
|
SPECIAL FEATURE |
 Type 2
Diabetes in Children:
Marilyn Porter brings us very important
information if you are educating children. Please read and Learn! “Adults and
Children: Is There a Difference in Learning?”
By Marilyn Porter, RD, CDE |
| |
|
Shafer Monthly Feature
|
|
 Exercise:
A Key Treatment for Type 2 Diabetes
Learn
about Exercise and how to introduce it to your patients for better
results. Full
aritcle
By Sherri
Shafer, R.D., CDE, |
|
|
|
SPECIAL FEATURE
|
|
 Dr.
Walter Willett, M.D., Professor of Epidemiology and Nutrition
and Chair of the Department of Nutrition, Harvard University shares
his comments on the current view that all 'complex'
carbohydrates are good, all fats are bad.
|
|
|
|
Dr. Thomas Burke Ph.D
|
 Dr. Burke
brings you a case history from Mary Lu W. an RN, CDE, from
Milwaukee, who has had Type 1 diabetes for 35 years and DPN for
5. Mary Lu shares her experience with the Anodyne Therapy System.
Click
Here |
| |
|
INSIDE
DIABETES |
|
 David Kliff shares his thoughts
on Novo Nordisk’s announcement of 1st quarter results
at
Inside Diabetes
David Kliff, Publisher The Diabetic
Investor
|
|
|
|
FEATURE
PRODUCT |
|
 The Only Test that tells
you, how your diabetes is progressing. A1cNow Hemoglobin
Test, the first ever at home test for HbA1c. Act now and receive
discounts off the purchase price of the single pack, the two
pack! and the 10 test kit. http://www.a1cnow.net/
DIABETES WILL NOT WAIT!…..NOT EVEN 8 MINUTES
|
|
|
|
A New Program |
|
The Pharmacy 15 minute
Diabetes ConSult with A1cNow™
A new program for pharmacies to help their
patients with diabetes and generate income by getting reimbursed for
the pharmacist’s knowledge, not just once, but 4 times a year.
Click
Here
|
| |
|
SUBSCRIBE |
|
| |
|
This
Weeks Newsletter
May 8, 2002, Issue 103
From the Editors
Desk:
Next week is our 2 year
anniversary. It has been a wonderful experience for us. With
your suggestions and support, we have gone from 35 subscribers for
our first issue to almost 30,000 subscribers. Thanks again for
your great support, we have grown due to your support.
This week we have 2 announcements from
last weeks AACE convention in Chicago that our publisher, Steve
Freed attended.
I walked in the JDRF Tampa Bay walk on
Sunday, thanks to the over 100 readers, who contributed to team
DIABETES IN CONTROL, we raised over 900.00. If you would like to
contribute whether it's a dollar or a hundred dollars click here.
A number of your peers wrote in with
suggestion on how to change the "Action
Plan" to make it even better. So we made the changes and
it is available to you to print. "Tools" for your practice. The
New "Action Plan" for your patients will cause them to make their
own commitment to diabetes care.
Starting next week in our Anniversary
Issue, we have made arrangements to have Dr. Evan Rosen, M.D.,
Ph.D. and Assistant Professor of Medicine, Harvard Medical School
share with us every 2 weeks a new feature on Diabetes. Don't
miss the first feature in our 2 year anniversary issue of Diabetes
In Control next week: "How does a cell turn off the signal given
by insulin once the message has been delivered? This is a critical
issue!
Also starting next week, Kristina
Sandstedt, MS, a Certified Exercise Specialist through the
American College of Sports Medicine will be joining us as a
columnist. She is currently the Clinical Exercise Physiologist and
Diabetes Educator for the Early Outpatient Phase II Cardiovascular
Rehabilitation unit and the outpatient Diabetes Self-Management
classes at Boone Hospital Center in Columbia, Missouri. Kristina
will be focusing on Exercise and helping you ensure your patients
success.
Dr. Freedland continues his series "Why
Focusing On Intensive Glucose Control With Drugs Alone Is
Counterproductive" with Part 4 How do Insulin, Tumor
necrosis factor-alpha, and Fat affect Vascular Inflammation?
This is
the last week to get in your names to win one of 3 scholarships to
the AADE conference.
Our Leaders
are Russ Brewer 713, Joann Henry 477, Connie Kleinbeck 374,
Birgetta Rice 363, and Cordele Atkins 352, remember we have 8
other prizes also:
To see the
current standings click here
Consider making Diabetes in Control Your home
page.
Dave Joffe, Editor-in-Chief ; Steve
Freed, Publisher
1. AACE:
Long-term Lipid Benefits of Pioglitazone for Patients with Type 2
Diabetes
Click Here
2. AACE:
Inhaled Insulin Shows Better Results Subcutaneous Formulation*
Click
Here
3. Item
Revisited: IGT is a More Advanced Stage of Alteration in the
Glucose Metabolism than IFG
Click
Here
4. Multiple
Injections in Type 2 Diabetics Not Effective Long-Term
Click
Here
5. Not All Glitazone Drugs Toxic to
Liver
Click
Here
6. New
Model Predicts a Person’s Risk for Type 2 Diabetes*
Click
Here
7. Avandia and Metformin have Synergistic
Effects for Improved Glycemic Control in High-Risk Diabetes
Patients
Click
Here
8. A Cure for Type 2 Diabetes, Is It
Possible?
Click
Here
9.
Pre-Diabetes is Treatable and Billable!
Click
Here
10. Cozaar
Comes Out on Top in Preventing Stroke and Diabetes
Click
Here
11. New Diabetes Drug Shows Promise!*
Click
Here
12.
Conventional Diet, Exercise Yields More Sustained Weight Loss in
Type 2 Diabetes
Click Here
13. Quality
of U.S. Diabetes Care is Below Standard!
Click
Here
14. Statins, Are They For All Your Diabetic and
Non-Diabetic Patients?
Click Here
15. Dietary Oat Fiber Reduces Need for
Antihypertensive Medication
Click Here
Special Notice
DON’T FORGET TO CHECK YOU MAILBOXES NEXT WEEK FOR
OUR 104TH ANNIVERSARY ISSUE!
News Flash - News Flash
Inhaled
Insulin shows showed
significantly greater decreases in both fasting plasma glucose
concentrations (a measurement taken before breakfast) and two-hour
post-prandial glucose levels (a measurement taken after a meal)
compared to patients who took only insulin injections.
See
Item #2:
OPEN STUDY
FOR
YOUR PARTICIPATION  Study #12
Room for a few more! Don’t miss this opportunity!
The Patient Experience Program – We
have over 50 educators and 500 patients registered for the
study. We still need 8
more educators who can provide 10 patients for the study. The
Patient Experience Program (PEP) seeks to bridge research and
educational programs to healthcare professionals, patients and their
families through a collaborative effort to promote public health and
to help people with Type 2 diabetes improve their quality of
life.
Honorariums
Paid Click Here!
2 NEW
STUDIES WILL BE STARTING NEXT MONTH
ITEM REVISITED
Item #3 Revisited from Issue
#83 Oct. 10, 2001
Impaired
Glucose Tolerance is a More Advanced Stage of Alteration in the
Glucose Metabolism than Impaired Fasting Glucose
Quote of the Week
"The
ability to become highly physically conditioned is malleable and
modifiable no matter what your age."
Andrew
Goldberg, director of the Geriatric Research, Education and Clinical
Center at the Baltimore VA Medical Center
| |
|
.jpg)